External mid-term, formative evaluation of the optimizing HIV treatment access (OHTA) for pregnant and breastfeeding women initiative in Uganda, Malawi, Ivory Coast and the Democratic Republic of Congo (DRC)
External mid-term, formative evaluation of the optimizing HIV treatment access (OHTA) for pregnant and breastfeeding women initiative in Uganda, Malawi, Ivory Coast and the Democratic Republic of Congo (DRC)
Eliminating mother to child transmission of HIV (E-MTCT) is at the forefront of HIV-prevention strategies. Several countries in sub-Saharan Africa (Malawi, Democratic Republic of Congo, Rwanda and Uganda) have shifted to WHO PMTCT Option B+ policy, a pragmatic public health approach which involves lifelong HAART for HIV infected pregnant women irrespective of their CD4 count1. The rationale behind option B+ is that it will enable better access to treatment in settings with limited access to CD4 testing, will have benefits beyond MTCT for the woman’s own health, facilitate the prevention of sexual transmission to uninfected partners and protect future pregnancies.
View the complete External mid-term, formative evaluation of the optimizing HIV treatment access (OHTA) for pregnant and breastfeeding women initiative in Uganda, Malawi, Ivory Coast and the Democratic Republic of Congo (DRC) report